Lonza completes divestment of two sites to NextPharma
Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies
Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies
Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
Lonza maintained business continuity during the COVID-19 pandemic with minimal impacts to operations and supply throughout 2020.
Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
New Board of Directors and management team at Suven Pharma also appointed
40,000 visitors and representatives of more than 80 countries set to visit the show
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
Meets the growing need for US-based API solubility and bioavailability enhancement services
Subscribe To Our Newsletter & Stay Updated